gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate

gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate Struktur
92923-44-9
CAS-Nr.
92923-44-9
Englisch Name:
gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
Synonyma:
dotaremR;gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate;[1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7,κO10]-gadolinate(1-) SodiuM;Gadolinate(1-), [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7,kO10]-,sodium (1:1)
CBNumber:
CB91396983
Summenformel:
C16H24GdN4O8*Na
Molgewicht:
0
MOL-Datei:
92923-44-9.mol

gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate Eigenschaften

Sicherheit

gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

[1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7,κO10]-gadolinate(1-) Sodium is an impurity of Gadoteridol (G125900), an MRI contrast chelating agent.

gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
jkinfo@jkchemical.com China 96815 76
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226
sales@rrkchem.com China 56086 58

  • gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate
  • [1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7,κO10]-gadolinate(1-) SodiuM
  • Gadolinate(1-), [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7,kO10]-,sodium (1:1)
  • dotaremR
  • 92923-44-9
  • C16H24GdN4O8Na
Copyright 2019 © ChemicalBook. All rights reserved